Hypercapnic acidosis modulates inflammation, lung mechanics, and edema in the isolated perfused lung.
OBJECTIVE
Low tidal volume (V(T)) ventilation strategies may be associated with permissive hypercapnia, which has been shown by ex vivo and in vivo studies to have protective effects. We hypothesized that hypercapnic acidosis may be synergistic with low V(T) ventilation; therefore, we studied the effects of hypercapnia and V(T) on unstimulated and lipopolysaccharide-stimulated isolated perfused lungs.


METHODS
Isolated perfused rat lungs were ventilated for 2 hours with low (7 mL/kg) or moderately high (20 mL/kg) V(T) and 5% or 20% CO(2), with lipopolysaccharide or saline added to the perfusate.


RESULTS
Hypercapnia resulted in reduced pulmonary edema, lung stiffness, tumor necrosis factor alpha (TNF-alpha) and interleukin 6 (IL-6) in the lavage and perfusate. The moderately high V(T) did not cause lung injury but increased lavage IL-6 and perfusate IL-6 as well as TNF-alpha. Pulmonary edema and respiratory mechanics improved, possibly as a result of a stretch-induced increase in surfactant turnover. Lipopolysaccharide did not induce significant lung injury.


CONCLUSIONS
We conclude that hypercapnia exerts a protective effect by modulating inflammation, lung mechanics, and edema. The moderately high V(T) used in this study stimulated inflammation but paradoxically improved edema and lung mechanics with an associated increase in surfactant release.
De Smet
Hilde R
HR
Flinders University, Bedford Park, South Australia 5042, Australia.
Bersten
Andrew D
AD
Barr
Heather A
HA
Doyle
Ian R
IR
D000142:Acidosis, Respiratory / Q000378:metabolism*; D000818:Animals; D016207:Cytokines / Q000378:metabolism; D006935:Hypercapnia / Q000378:metabolism*; D007249:Inflammation; D008070:Lipopolysaccharides; D008168:Lung / Q000098:blood supply / Q000378:metabolism*; D008297:Male; D011654:Pulmonary Edema / Q000517:prevention & control*; D011663:Pulmonary Surfactants / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D012121:Respiration, Artificial / Q000379:methods*; D015656:Respiratory Mechanics
D016207:Cytokines; D008070:Lipopolysaccharides; D011663:Pulmonary Surfactants